Outcomes of cytomegalovirus retinitis following the use of ganciclovir implants

Australian and New Zealand Journal of Ophthalmology

Volumn 26, Issue 3, 1998, Pages 207-210

  McCluskey, Peter J ^a,b,d   Shah, Rajiv ^b   Versace, Patrick ^c  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d NONE   (Australia)

Author keywords

Cytomegalovirus retinitis; Ganciclovir implants

Indexed keywords

GANCICLOVIR;

ADULT; ARTICLE; CATARACT; DRUG EFFECT; DRUG EFFICACY; DRUG IMPLANT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; RETINA DETACHMENT; RETINITIS; VITREOUS HEMORRHAGE;

EID: 0031857681     PISSN: 08149763     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.1998.tb01312.x     Document Type: Article

References (16)

1. Hoover DR, Saah AJ, Bacellar H et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis: Multicenter AIDS cohort study. N. Engl. J. Med. 1993; 329: 1922-6.
2. Jacobson M. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1997; 337: 105-14.
3. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N. Engl. J. Med. 1992; 326: 213-20.
4. The Oral Ganciclovir European and Australian Cooperative Study Group. Intravenous in oral ganciclovir: European/ Australian comparative study of efficacy and safety in the prevention of CMV retinitis recurrence in patients with AIDS. AIDS 1995; 9: 471-7.
5. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS. The HPMPC peripheral cytomegalovirus retinitis trial: A randomised controlled trial. Ann. Intern. Med. 1997; 126: 264-74.
6. McCluskey PJ, Hall AJ, Lightman S. HIV and eye disease. Med. J. Aust. 1996; 164: 484-6.
7. Smith TJ, Pearson PA, Blandford DL et al. Intravitreal sustained release ganciclovir. Arch. Ophthalmol. 1992; 110: 255-8.
8. Sanborn G, Anand R, Torti RE et al. Sustained release ganciclovir therapy for treatment of cytomegalovirus retinitis: Use of an intravitreal device. Arch. Ophthalmol. 1992; 110: 188-95.
9. Anand R, Nightingale SD, Fish RH et al. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch. Ophthalmol. 1993; 111: 223-7.
10. Martin DF, Parks DJ, Mellow SD et al. Treatment of cytomegalovirus retinitis with an intraocular sustained release ganciclovir implant: A randomised controlled clinical trial. Arch. Ophthalmol. 1994, 112: 1531-9.
11. Musch DC, Martin DF, Gordon JF, Davis MD, Kupperman BD, Ganciclovir Implant Study Group. Treatment of cytomegalovirus retinitis with an intraocular sustained release ganciclovir implant. N. Engl. J. Med. 1997; 337: 83-90.
12. Holland GN, Tufail A, Jordan MC. Cytomegalovirus diseases. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection and immunity. St Louis: Mosby Year Book, 1996; 1088-129.
13. Luckie A, Ai E. Sustained release intravitreal ganciclovir pellets in the treatment of cytomegalovirus retinitis in the acquired immunodeficiency syndrome. Aust. N.Z. J. Ophthalmol. 1995; 23: 157-8.
14. Davis JL, Serfass MS, Lai M-K, Trask DK, Azen SP. Silicone oil in repair of retinal detachments due to necrotizing retinitis in HIV infection. Arch. Ophthalmol. 1995; 113: 1401-9.
15. McCluskey PJ, Grigg J, Playfair TJ. Retinal detachments in patients with AIDS and CMV retinopathy. Br. J. Ophthalmol. 1995; 79: 153-6.
16. Jacobson MA, Zegans M, Pavan PR et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349: 1443-5.